Mechanism
HPV16 E7 (HLA-A*02:01) + MAGE-C2 (HLA-B*07:02), combination
Assets acting on this target.
- Class
- Combination of two HLA-restricted, autologous TCR-T cell products ('T-Plex')
- Pathway
- MHC class I-restricted antigen recognition driving T cell-mediated tumor cytotoxicity, dual-antigen targeting
Research
Sign in to access ResearchExplore this mechanism at different depths
Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.
0 of 0 assets
No assets match these filters.